Apoptotic and proliferation indexes in primary superficial bladder tumors

被引:18
作者
Gonzalez-Campora, Ricardo
Davalos-Casanova, Guillermo
Beato-Moreno, Antonio
Luque, Rafael J.
Alvarez-Kindelan, Jose
Requena, Maria J.
Montironi, Rodolfo
Lopez-Beltran, Antonio
机构
[1] Virgen Macarena Univ Hosp, Dept Pathol, Seville 41009, Spain
[2] Univ Seville, Sch Med, Seville, Spain
[3] San Carlos Mil Hosp, Dept Urol, San Fernando De Henares, Spain
[4] Univ Seville, Dept Stat & Operat Res, Seville, Spain
[5] Univ Hosp Jaen, Dept Pathol, Jaen, Spain
[6] Reina Sofia Univ Hosp, Dept Urol, Cordoba, Spain
[7] Reina Sofia Univ Hosp, Dept Pathol, Cordoba, Spain
[8] Univ Cordoba, Sch Med, Cordoba, Spain
[9] Univ Politecn Marche Reg, Inst Pathol Anat & Histopathol, Ancona, Italy
关键词
bladder cancer; apoptosis; Ki-67;
D O I
10.1016/j.canlet.2005.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Whether apoptotic index [AI] and/or Ki-67 labeling index [Ki-67LI] add prognostic information in bladder cancer remains unclear. Mean AI and Ki-67 LI increased with grade and stage in 147 superficial bladder tumors. AI (> 1.7%) correlated with tumor size, grade and proliferation. Ki-67 LI (> 10%) correlated with higher grade and stage. Tumor size and Ki-67 LI were independent predictors of disease-free and progression-free survival, respectively. Tumor size, patient's age and tumor's recurrence predicted overall survival. We conclude that conventional clinical parameters and Ki-67 LI define risk groups of bladder tumors, while AI has limited value. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:266 / 272
页数:7
相关论文
共 29 条
[1]   Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of P53 and Bcl-2 [J].
Amirghofran, Z ;
Monabati, A ;
Khezri, A ;
Malek-Hosseini, Z .
PATHOLOGY & ONCOLOGY RESEARCH, 2004, 10 (03) :154-158
[2]   Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks [J].
Bol, MGW ;
Baak, JPA ;
van Diermen, B ;
Buhr-Wildhagen, S ;
Janssen, EAM ;
Kjellevold, KH ;
Kruse, AJ ;
Mestad, O ;
Ogreid, P .
JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (06) :447-452
[3]  
Cina SJ, 2001, ARCH PATHOL LAB MED, V125, P646
[4]   P27Kip1 and Ki-67 expression analysis in transitional cell carcinoma of the bladder [J].
Dybowski, B ;
Kupryjanczyk, J ;
Rembiszewska, A ;
Pykalo, R ;
Borkowski, A .
UROLOGICAL RESEARCH, 2003, 31 (06) :397-401
[5]  
Fradet Y, 2000, Curr Opin Urol, V10, P441, DOI 10.1097/00042307-200009000-00013
[6]   Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications [J].
Giannopoulou, I ;
Nakopoulou, L ;
Zervas, A ;
Lazaris, AC ;
Stravodimos, C ;
Giannopoulos, A ;
Davaris, PS .
UROLOGICAL RESEARCH, 2002, 30 (05) :342-345
[7]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[8]   Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: Association with tumor progression [J].
King, ED ;
Matteson, J ;
Jacobs, SC ;
Kyprianou, N .
JOURNAL OF UROLOGY, 1996, 155 (01) :316-320
[9]   Differential expression of bcl-2 family proteins in bladder carcinomas relationship with apoptotic rate and survival [J].
Korkolopoulou, P ;
Lazaris, AC ;
Konstantinidou, AE ;
Kavantzas, N ;
Patsouris, E ;
Christodoulou, P ;
Thomas-Tsagli, E ;
Davaris, P .
EUROPEAN UROLOGY, 2002, 41 (03) :274-283
[10]   Apoptosis in carcinoma of the bladder:: Relation with radiation treatment results [J].
Lara, PC ;
Pérez, S ;
Rey, A ;
Santana, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (05) :1015-1019